MPWT
VIR icon

MassMutual Private Wealth & Trust’s Vir Biotechnology VIR Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.29K Hold
323
– – ﹤0.01% 1835
2026
Q1 		$2.89K Buy
323
+272
+533% +$2.17K ﹤0.01% 1872
2025
Q4 		$308 Sell
51
-28
-35% -$167 ﹤0.01% 2292
2025
Q3 		$451 Buy
+79
New +$404 ﹤0.01% 2252
2025
Q2 		– Sell
-793
Closed -$5.14K – 2496
2025
Q1 		$5.14K Buy
793
+202
+34% +$1.8K ﹤0.01% 1593
2024
Q4 		$4.34K Sell
591
-44
-7% -$347 ﹤0.01% 1578
2024
Q3 		$4.76K Sell
635
-371
-37% -$3.22K ﹤0.01% 1404
2024
Q2 		$8.95K Sell
1,006
-14
-1% -$134 ﹤0.01% 1133
2024
Q1 		$10.3K Buy
1,020
+419
+70% +$4.27K ﹤0.01% 1033
2023
Q4 		$6.05K Buy
601
+427
+245% +$3.9K ﹤0.01% 1181
2023
Q3 		$1.63K Buy
174
+110
+172% +$1.57K ﹤0.01% 1556
2023
Q2 		$1.57K Buy
+64
New +$1.61K ﹤0.01% 1541
2022
Q4 		– Sell
-51
Closed -$1K – 1870
2022
Q3 		$1K Sell
51
-16
-24% -$407 ﹤0.01% 1553
2022
Q2 		$2K Buy
+67
New +$1.56K ﹤0.01% 1214

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

MassMutual Private Wealth & Trust's VIR Position: Q2 2026 in Review

MassMutual Private Wealth & Trust held its Vir Biotechnology (VIR) position steady in Q2 2026 at 323 shares worth $3.29K. The position accounts for ﹤0.01% of the portfolio, ranked #1835.

MassMutual Private Wealth & Trust first reported a position in VIR in Q2 2022 and has held it in 14 quarters since. The position peaked at $10.3K in Q1 2024. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • MassMutual Private Wealth & Trust held 323 shares of Vir Biotechnology worth $3.29K as of Q2 2026.
  • MassMutual Private Wealth & Trust left its Vir Biotechnology share count unchanged in Q2 2026.
  • Vir Biotechnology made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #1835 holding.
  • MassMutual Private Wealth & Trust first reported a position in Vir Biotechnology in Q2 2022 and has held it in 14 quarters since.
  • MassMutual Private Wealth & Trust's Vir Biotechnology position peaked at $10.3K in Q1 2024.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.